Apnimed Inc (APMD) News & EventsAPMDApnimed Inc

Lyntris Debuts Below Expectations, OpenAI Expects IPO in 2027

Lyntris makes market debut below expected range as OpenAI tells employees it still expects to go public in 2027.LATEST IPOS AND DIRECT LISTINGS:Lyntrisopened on August 19 at $15.50. The defense technology company priced its initial public offering of 17M at $17.50, below the $19.00-$22.00 range.RECENT SPAC IPOS:Karman Line Acquisitionopened on August 18 at $9.95. The blank check company may pursue an initial business combination in any business, industry, sector or geographical location, but the company intends to focus on sectors "aligned with the creation or expansion of services and capabilities for or tangential to space based infrastructure, with a focus on the aerospace and defense sectors."PERFORMANCE:Prices as of 10:30 am ET on Monday, August 24 -Lyntris – down about 1% at $15.48.RECENT IPOS TO WATCH:Jersey Mike's Subsand Reformationare already seeing coverage roll out, while Apnimed, IMC Rare Earthsand Game Your Gameare among stocks that could see new coverage this week as the quiet periods for banks that underwrote the companies' IPOs expire.UPCOMING IPOS:Upcoming IPO and direct listings expected include EvoAirand Inspire Brands.Clickto see upcoming IPO calendar on TipRanks.OpenAI'sCFO Sara Friar told employees that the AI lab "will be a public company in 2027," CNBC's Ashley Capoot and Kate Rooney. In an all hands meeting, Friar told employees not to worry about rival Anthropic's IPO timeline. OpenAI confidentially filed its IPO prospectus with regulators in June, but it has not publicly disclosed its plans. "The IPO is not a finish line, it is a milestone, another fundraise," Friar told employees, according to two sources familiar with her comments. "We raised $122B in March, and that gives us flexibility."EvoAir Holdingshas filed for a firm commitment initial public offering of shares of common stock and anticipates that the initial public offering price of shares will be between $4.00 and $5.00 per share. The company said it will apply to list its common stock on the Nasdaq Capital Market under the symbol "EVOH". EvoAir Group is an emerging green technology focusing on eco-friendly heating, ventilation, air conditioning inventions and efforts in the environmental, social and governance initiatives. The Group is principally engaged in the research and development, manufacturing, sale and marketing of HVAC products for residential, commercial and industrial uses.Inspire Brandsannounced that it has confidentially submitted a draft registration statement on Form S-1 with the Securities and Exchange Commission relating to the proposed initial public offering of its common stock. Inspire Brands expects to use the net proceeds of the proposed offering to repay outstanding indebtedness under its existing term loan facility and pay offering fees and expenses."Opening Day" is The Fly's recurring series of stories on the latest initial public offerings, their performance, and upcoming IPOs.

Jersey Mike's and Reformation Debut with Muted Performance

Jersey Mike's and Reformation opened for trading last week with muted debuts, testing demand for consumer names at a time when the category has struggled to regain momentum.LATEST IPOS AND DIRECT LISTINGS:Apnimedopened on July 31 at $22.00. The company priced 12M shares at $16.00. The deal size was increased to 12M shares from 10M shares of common stock and priced at the high-end of the $14.00-$16.00 range. Apnimed is a late stage clinical pharmaceutical company dedicated to the discovery, development, and commercialization of novel oral therapies that address the neurobiology of sleep-related breathing diseases.Jersey Mike's Subsopened on July 30 at $21. The company priced 43.48M shares at $23.00. The deal priced at the midpoint of the $21.00-$25.00 target range. Jersey Mike's Subs is a fast-casual restaurant franchisor with more than 3,300 locations across the United States and Canada.Reformationopened on July 30 at $15. The company priced 14.06M shares at $15.00, the low end of the $15.00-$17.00 target range. Reformation is a sustainable womenswear brand that operates 70 retail stores across the U.S., U.K., Canada and France.Game Your Gamebegan trading on Nasdaq on July 30 after a direct listing. The golf technology company based in Palo Alto, California began trading on the Nasdaq Capital Market under the ticker symbol "GYGY" following a direct listing. Chief Executive Officer Soumya Das said the company is "focused on completing our commercial launch, scaling our subscriber base, and building on our GameGolf AI platform."IMC Rare Earthsopened on July 29 at $5.18. The company priced 4M shares at $5.00. IMC, which is advancing the Itarantim project, a large-scale clay deposit in northeastern Brazil that is especially rich with dysprosium and terbium, two rare earth magnet elements with multiple commercial and strategic applications, reports that the project's inferred mineral resource is estimated at approximately 1.1 billion metric tons.RECENT SPAC IPOS:Churchill Capital XIIIopened on July 31 at $10.31. The company priced its upsized initial public offering of 36M units at $10.00 per unit.PERFORMANCE:Prices as of 11 am ET on Monday, August 3 -Apnimed – up more than 4% at $26.06;Jersey Mike's Subs – up almost 4% at $24.02;Reformation – up over 1% at $16.43;Game Your Game – down almost 26% at $6.74;IMC Rare Earths – up about 15% at $6.29;UPCOMING IPOS:Upcoming IPO and direct listings expected include EvoAir, Braveheart Bio, and Inspire Brands.Clickto see upcoming IPO calendar on TipRanks.EvoAir Holdings has filed for a firm commitment initial public offering of shares of common stock and anticipates that the initial public offering price of shares will be between $4.00 and $5.00 per share. The company said it will apply to list its common stock on the Nasdaq Capital Market under the symbol "EVOH". EvoAir Group is an emerging green technology focusing on eco-friendly heating, ventilation, air conditioning inventions and efforts in the environmental, social and governance initiatives. The Group is principally engaged in the research and development, manufacturing, sale and marketing of HVAC products for residential, commercial and industrial uses.Braveheart Biohas filed with the SEC for an initial public offering of shares of its common stock and applied to list its common stock on The Nasdaq Global Market under the symbol "BRVE". Goldman Sachs, Jefferies, TD Cowen, Stifel and Cantor are listed as the joint bookrunners. The prospectus states, "We are a clinical-stage biopharmaceutical company focused on developing therapies for patients with hypertrophic cardiomyopathy and other serious cardiovascular diseases. Our lead product candidate, BHB-1893, is a next-generation oral small-molecule cardiac myosin inhibitor, that we are developing for the treatment of obstructive HCM and non-obstructive HCM."Inspire Brandsannounced that it has confidentially submitted a draft registration statement on Form S-1 with the Securities and Exchange Commission relating to the proposed initial public offering of its common stock. Inspire Brands expects to use the net proceeds of the proposed offering to repay outstanding indebtedness under its existing term loan facility and pay offering fees and expenses."Opening Day" is The Fly's recurring series of stories on the latest initial public offerings, their performance, and upcoming IPOs.

Apnimed Prices 12M Shares at $16.00

Apnimed priced 12M shares at $16.00. The deal size was increased to 12M shares from 10M shares of common stock and priced at the high-end of the $14.00-$16.00 range. BofA, Evercore ISI, Cantor Fitzgerald and LifeSci Capital acted as joint book running managers for the offering. Apnimed is a late stage clinical pharmaceutical company dedicated to the discovery, development, and commercialization of novel oral therapies that address the neurobiology of sleep-related breathing diseases.